fbpx
January 9, 2023

New Trials in Leukemia and Lymphoma: Could Your Patient Benefit? New Trials in Leukemia and Lymphoma: Could Your Patient Benefit?

Several clinical trials investigating new drugs in the treatment of leukemia and lymphoma have started in recent months. Maybe one of your patients could benefit from […]
January 6, 2023

Recount of FOURIER Data Finds Higher Mortality With Evolocumab Recount of FOURIER Data Finds Higher Mortality With Evolocumab

Readjudication of mortality data from the FOURIER trial suggests a higher risk for cardiovascular death with evolocumab (Repatha) among patients with established atherosclerotic cardiovascular disease than […]
January 6, 2023

Travel Curbs Rack Up as COVID-Hit China Readies Reopening Travel Curbs Rack Up as COVID-Hit China Readies Reopening

SHANGHAI/BEIJING (Reuters) – More countries around the world are demanding that visitors from China take COVID tests, days before it drops border controls and ushers in […]
January 6, 2023

Pfizer Explores Options for Some Rare Disease, Cancer Drugs Pfizer Explores Options for Some Rare Disease, Cancer Drugs

(Reuters) – Pfizer Inc is exploring options for some early-stage treatments for rare diseases and cancer in a bid to focus on “high-impact” medicines and vaccines, […]
January 6, 2023

Graphite Bio Pauses Early Stage Blood Disease Therapy Trial Graphite Bio Pauses Early Stage Blood Disease Therapy Trial

(Reuters) – Gene therapy firm Graphite Bio said on Thursday it was pausing an early-to-mid-stage trial of its blood disease therapy due to a serious adverse […]
January 6, 2023

Moderna Signs $35 Million Deal With Cancer Drug Developer CytomX Moderna Signs $35 Million Deal With Cancer Drug Developer CytomX

(Reuters) – Moderna Inc on Thursday announced a $35 million licensing deal with cancer-focused drug developer CytomX Therapeutics to work on messenger RNA-based therapies for a […]
January 6, 2023

Vitamin D Relieved Toxic Erythema of Chemotherapy in Small Study Vitamin D Relieved Toxic Erythema of Chemotherapy in Small Study

High-dose vitamin D led to improvement of toxic erythema of chemotherapy (TEC) within 1 to 4 days in a retrospective case series of six patients seen on […]
January 6, 2023

Little-Used Fitness Measure May Be Key for Exercise Prescriptions Little-Used Fitness Measure May Be Key for Exercise Prescriptions

There’s been a push in recent years encouraging doctors to prescribe exercise as medicine, telling their patients how often, how long, and how hard to work out […]
January 6, 2023

Novel Topical Treatment for Molluscum Under Review at FDA Novel Topical Treatment for Molluscum Under Review at FDA

A new drug application for berdazimer gel 10.3% for treating molluscum contagiosum (MC) has been submitted to the Food and Drug Administration, the manufacturer announced. If […]
Prev page
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435436437438439440441442443444445446447448449450451452453454455456457458459460461462463464465466467468469470471472473474475476477478479480481482483484485486487488489490491492493494495496497498499500501502503504505506507508509510511512513514515516517518519520521522523524525526527528529530531532533534535536537538539540541542543544545546547548549550551552553554555556557558559560561562563564565566567568569570571572573574575576577578579580581582583584585586587588589590591592593594595596597598599600601602603604605606607608609610611612613614615616617618619620621622623624625626627628629630631632633634635636637638639640641642643644645646647648649650651652653654655656657658659660661662663664665666667668669670671672673674675676677678679680681682683684685686687688689690691692693694695696697698699700701702703704705706707708709710711712713714715716717718719720721722723724725726727728729730731732733734735736737738739740741742743744745746747748749750751752753754755756757758759760761762763764765766767768769770771772773774775776777778779780781782783784785
Next page
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0